SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 53 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $9,000 | -90.9% | 35,114 | -29.0% | 0.00% | – |
| Q3 2018 | $99,000 | -39.6% | 49,450 | -36.1% | 0.00% | – |
| Q2 2018 | $164,000 | +1950.0% | 77,379 | +2438.7% | 0.00% | – |
| Q1 2018 | $8,000 | -90.4% | 3,048 | -86.4% | 0.00% | – |
| Q4 2017 | $83,000 | +277.3% | 22,434 | +91.4% | 0.00% | – |
| Q3 2017 | $22,000 | +46.7% | 11,723 | +177.8% | 0.00% | – |
| Q4 2016 | $15,000 | +87.5% | 4,220 | +133.8% | 0.00% | – |
| Q3 2016 | $8,000 | – | 1,805 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,133,583 | $4,104,000 | 3.61% |
| GREAT POINT PARTNERS LLC | 1,537,873 | $5,567,000 | 1.14% |
| BVF INC/IL | 1,392,720 | $5,042,000 | 1.01% |
| Boxer Capital, LLC | 525,000 | $1,901,000 | 0.74% |
| Vivo Capital, LLC | 500,000 | $1,810,000 | 0.60% |
| Healthcare Value Capital, LLC | 150,000 | $543,000 | 0.58% |
| Cormorant Asset Management, LP | 1,000,000 | $3,620,000 | 0.49% |
| Telemetry Investments, L.L.C. | 120,807 | $437,000 | 0.25% |
| Palo Alto Investors LP | 1,162,473 | $4,208,000 | 0.24% |
| NEA Management Company, LLC | 1,298,274 | $4,700,000 | 0.19% |